Skip to main content
Shanghai Medicilon Inc. logo

Shanghai Medicilon Inc. — Investor Relations & Filings

Ticker · 688202 ISIN · CNE100003NQ8 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 817 across all filing types
Latest filing 2021-04-15 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688202

About Shanghai Medicilon Inc.

https://www.medicilon.com.cn/

Shanghai Medicilon Inc. is a comprehensive contract research organization providing integrated drug discovery and development services to the global pharmaceutical and biotechnology sectors. The company offers a full spectrum of preclinical services, including medicinal chemistry, lead optimization, in vitro and in vivo biology, pharmacology, and drug metabolism and pharmacokinetics (DMPK). Medicilon specializes in safety evaluation and toxicology studies conducted in GLP-compliant facilities to support Investigational New Drug (IND) applications. Its integrated platform facilitates the transition of drug candidates from initial discovery through preclinical development, covering both small molecule drugs and biologics. By leveraging advanced technology and scientific expertise, the company assists clients in accelerating drug development timelines and optimizing research outcomes.

Recent filings

Filing Released Lang Actions
美迪西：第二届董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 14th meeting of the 2nd Board of Directors of Shanghai Medicilon Inc. It includes multiple agenda items such as approval of the 2020 Board Work Report, General Manager Work Report, Independent Directors' Report, Audit Committee Report, 2020 Financial Statements, Profit Distribution Plan, Annual Report, and other governance and financial matters. The document repeatedly states that these items will be submitted to the shareholders' meeting for approval and provides links to the full reports on the Shanghai Stock Exchange website. The document is a formal board meeting resolution announcement, not the actual annual report or financial statements themselves. It contains no full financial statements or substantive financial data but rather approvals and summaries. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board decisions and management matters.
2021-04-15 Chinese
美迪西：2020年度审计报告及财务报表
Regulatory Filings
2021-04-15 Chinese
美迪西：独立董事关于公司2020年的对外担保情况的专项说明
Regulatory Filings
2021-04-15 Chinese
美迪西：关于召开2020年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a notice about the convening of the 2020 Annual General Meeting (AGM) of Shanghai Medicilon Inc., including details such as the meeting date, voting methods, agenda items, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports will be discussed and voted on. The document length is 3529 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2021-04-15 Chinese
美迪西：关于公司变更会计政策的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shanghai Medicilon Inc. regarding a change in accounting policy related to the adoption of a new lease accounting standard effective from January 1, 2021. It details the reasons for the change, the approval process by the board and supervisory committee, and includes independent directors' and supervisors' opinions. The document does not contain financial statements or substantive financial data but is a formal announcement of the accounting policy change. It is not a full annual or interim report, audit report, or earnings release. Given the nature of the content as a formal announcement about accounting policy changes and approvals, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-15 Chinese
美迪西：2020年度独立董事述职报告
Regulatory Filings
2021-04-15 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.